Precision Medicine News and Research

RSS

U-M lab receives $13.2 million NIDA grant to optimize interventions for substance abuse disorders

A University of Michigan lab focused on developing cutting-edge methods to inform effective interventions for drug abuse, HIV and other chronic conditions has been awarded a $13.2 million grant from the National Institute on Drug Abuse.

28 Sep 2021

Researchers release guidance to address pathology aspects in clinical trial protocols

An international group of cancer researchers, led by the National Cancer Research Institute's (NCRI) Cellular Molecular Pathology Initiative (CMPath), has published guidance to address the variability in how pathology is planned and delivered in clinical trials.

28 Sep 2021

New discovery greatly improves detection of HPV in the bloodstream

Princess Margaret Cancer Centre researchers have made new findings which greatly improve detection of the human papillomavirus (HPV) in the bloodstream and could further hone precision treatment of the illness.

27 Sep 2021

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with a clear emphasis on precision medicine.

24 Sep 2021

Cardiotoxic effects of common chemotherapy drug could be prevented

Harmful side effects from a common chemotherapy drug could be the result of a single mutation, according to a study published in Cell Stem Cell.

24 Sep 2021

New 3D pancreatic cancer model could be used to develop and test targeted treatments

An international team of scientists have created a three-dimensional (3D) pancreatic cancer tumour model in the laboratory, combining a bioengineered matrix and patient-derived cells that could be used to develop and test targeted treatments.

24 Sep 2021

Study identifies master regulator behind the development of antibody-producing cells

The master regulator behind the development of antibody-producing cells has been identified in a study by investigators at Weill Cornell Medicine. The findings provide new insight into the inner workings of the immune system and may help understand how tissues develop and how certain cancers arise.

24 Sep 2021

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

To coincide with World Alzheimer’s Month, EIT Health, an EU-backed network of best-in-class health innovators, has highlighted the urgent need to focus on implementing bolder approaches to the treatment of Alzheimer’s Disease post-pandemic.

20 Sep 2021

R37 MERIT Award supports innovative ovarian cancer research

One of the most impactful advancements during the past decade in treating ovarian cancer is the use of PARP inhibitors (short for poly adenosine diphosphate-ribose polymerase). PARP inhibitors are a type of cancer drug that blocks the PARP enzyme from helping to repair DNA damage in cancer cells.

18 Sep 2021

Owlstone Medical appoints Mark Capone to board of directors

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the appointment of Mark Capone, former President and CEO of Myriad Genetics to its Board as an independent non-executive director.

From Owlstone Medical Ltd 17 Sep 2021

Organs-on-chips for personalized medicine and to assess drug efficacy

Organs-on-chips could be used to assess drug efficacy and support personalized medicine, write Adrian Roth and colleagues in a Perspective.

17 Sep 2021

AAHD expands collaboration with National Institutes of Health's All of Us Research Program

The American Association on Health and Disability is excited to expand its collaboration with the National Institutes of Health's All of Us Research Program.

16 Sep 2021

Improving optical tissue clearing method for better cancer diagnosis

When it comes to cancer, clarity is key. The ability to visualize cancerous tumors and metastatic tissue three dimensionally (3D) can help clinicians diagnose the precise type and stage of cancer, while also informing the best treatment methods.

16 Sep 2021

New genetic classifier can predict the sensitivity of neoadjuvant chemotherapy for breast cancer

A research team by Prof. YANG Wulin and DAI Haiming from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences recently proposed a genetic classifier that can predict the sensitivity of neoadjuvant chemotherapy for breast cancer in the field of tumor molecular markers.

15 Sep 2021

Researchers disprove natural antioxidant urate for slowing the progression of Parkinson’s disease

The hypothesis that raising the brain levels of the natural antioxidant urate could slow the progression of Parkinson's disease (PD) has been disproven by researchers at Massachusetts General Hospital.

14 Sep 2021

Researchers receive $12.8M renewal grant to reveal how smoking causes distinct lung diseases

Despite cigarette smoking being the single most preventable risk factor for both chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), two devastating diseases that make it hard to breathe, about 44 million American adults continue to smoke.

8 Sep 2021

Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy

Owlstone Medical today announced the close of its Series D financing round.

From Owlstone Medical Ltd 7 Sep 2021

Polygenic risk score no better at predicting psychosis outcomes than written reports, study finds

With the help of cutting-edge computer programs, researchers at the Icahn School of Medicine at Mount Sinai went through the genetic and medical records of more than 8,000 schizophrenia patients.

6 Sep 2021

Researchers develop a machine learning-based screening tool for genetic syndromes in children

With an average accuracy of 88%, a deep learning technology offers rapid genetic screening that could accelerate the diagnosis of genetic syndromes, recommending further investigation or referral to a specialist in seconds, according to a study published in The Lancet Digital Health.

2 Sep 2021

Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment

New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more likely to respond to siltuximab, the only FDA approved treatment for the disease.

2 Sep 2021

Precision Medicine News and Research

U-M lab receives $13.2 million NIDA grant to optimize interventions for substance abuse disorders

Researchers release guidance to address pathology aspects in clinical trial protocols

New discovery greatly improves detection of HPV in the bloodstream

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Cardiotoxic effects of common chemotherapy drug could be prevented

New 3D pancreatic cancer model could be used to develop and test targeted treatments

Study identifies master regulator behind the development of antibody-producing cells

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

R37 MERIT Award supports innovative ovarian cancer research

Owlstone Medical appoints Mark Capone to board of directors

Organs-on-chips for personalized medicine and to assess drug efficacy

AAHD expands collaboration with National Institutes of Health's All of Us Research Program

Improving optical tissue clearing method for better cancer diagnosis

New genetic classifier can predict the sensitivity of neoadjuvant chemotherapy for breast cancer

Researchers disprove natural antioxidant urate for slowing the progression of Parkinson’s disease

Researchers receive $12.8M renewal grant to reveal how smoking causes distinct lung diseases

Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy

Polygenic risk score no better at predicting psychosis outcomes than written reports, study finds

Researchers develop a machine learning-based screening tool for genetic syndromes in children

Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News